GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.05 (-3.54%)
Close on Nov 17, 2026Market cap $2.95MP/E –Yield –
GRI Bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
GRI Bio's profit margin for the twelve months ending Dec 31, 2020 was -4822.0%. For fiscal 2020 it was -4822.0%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -4822.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -1161.0% | – |
See a number that looks wrong?